Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Ventas, Inc.    VTR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on VENTAS, INC.
02/16DJVentas In Talks to Buy Part or All of Brookdale Senior Living -- Update
02/16DJVentas In Talks to Buy Part or All of Brookdale Senior Living
02/14 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
02/14 VENTAS,INC. (NYSE : VTR) Files An 8-K Other Events
02/14 VENTAS : Management's Discussion and Analysis of Financial Condition and Results..
02/10 VENTAS : VTR) Falls Ahead of Earnings
02/10 VENTAS : reports 4Q results
02/10 VENTAS INC : Results of Operations and Financial Condition, Other Events, Financ..
02/10 VENTAS : Reports 2016 Fourth Quarter and Full-Year Results
02/08 VENTAS : Research Reports Initiation on REIT Stocks -- HCP Inc., Medical Propert..
01/25 VENTAS, INC. (NYSE : VTR) Files An 8-K Departure of Directors or Certain O..
01/24 VENTAS INC : Change in Directors or Principal Officers (form 8-K)
01/18 VENTAS : Announces Tax Treatment of 2016 Distributions
01/11 VENTAS INC : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi..
01/10 VENTAS, INC. (NYSE : VTR) Files An 8-K Regulation FD Disclosure
01/10 VENTAS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
01/10 VENTAS : Comments on Full Year 2016 Expectations and Issues Preliminary 2017 Out..
2016 VENTAS : Technical Reports on REIT Stocks -- Medical Properties Trust, HCP Inc.,..
2016 VENTAS, INC. : ex-dividend day
2016 VENTAS : Increases Fourth Quarter 2016 Dividend by 6 Percent
2016 VENTAS : CEO to Participate in Harvard Business Review's Top 100 CEOs Panel Disc..
2016 VENTAS : CEO to Participate in Harvard Business Review’s Top 100 CEOs Pane..
2016 KINDRED HEALTHCARE, INC (NYSE : KND) Files An 8-K Announces Agreements With Vent..
2016 VENTAS : Announces Agreements With Kindred Healthcare to Facilitate Kindred&rsqu..
2016 VENTAS INC. : (VTR) Falls 4.07% for November 09
2016 VENTAS INC. : (VTR) is Trading Lower on Unusual Volume for November 08
2016 VENTAS : Time To Buy Ventas Already
2016 VENTAS : Comments on Kindred Healthcare Exit from Skilled Nursing Facility Busin..
2016 VENTAS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2016 VENTAS : reports 3Q results
2016 VENTAS INC : Results of Operations and Financial Condition, Financial Statements..
2016DJVENTAS : Boosts Outlook as Profit Soars
2016 VENTAS : Reports 2016 Third Quarter Results
2016 VENTAS : REIT Stocks Technical Reports -- Medical Properties Trust, HCP Inc., Ve..
2016 VENTAS : Pggm Investments buys $260,580,392 stake in Ventas
2016DJVENTAS : REITs Focused On Health Care Back Off Nursing -- WSJ
2016DJVENTAS : Health-Care REITs Back Off Nursing
2016 VENTAS : Announces Third Quarter 2016 Earnings Release Date and Conference Call
2016 VENTAS : Issues Secured Debt Financing Commitment for Ardent Health Services to ..
2016 ARDENT HEALTH SERVICES : And LHP Hospital Group, Inc. Announce Plans To Merge
2016 KINDRED HEALTHCARE : Completes Sale of 12 LTAC Hospitals to Curahealth
2016 VENTAS INC : Other Events (form 8-K)
2016 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2016DJVENTAS : Ernst & Young to Pay $9.3 Million to Settle Charges
2016 VENTAS : Can Be Used To Generate 12% To 17% Engineered Income
2016 VENTAS : Announces Pricing of Senior Notes Offering
2016 VENTAS, INC. : ex-dividend day
2016 VENTAS : Wexford Science & Technology to Become an Independent Company
2016 VENTAS : Completes Acquisition of Wexford’s Life Science and Medical Real ..
2016 VENTAS : Declares Regular Quarterly Dividend of $0.73 Per Share
2016 VENTAS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
2016DJVENTAS : Profit Falls Less Than Expected
2016 VENTAS : reports 2Q results
2016 VENTAS INC : Results of Operations and Financial Condition, Financial Statements..
2016 VENTAS : Reports 2016 Second Quarter Results
2016VENTAS, INC. : half-yearly earnings release
2016 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2016 VENTAS : Announces Second Quarter 2016 Earnings Release Date and Conference Call
2016 VENTAS : REIT acquires Wexford assets
2016 VENTAS : Blackstone sells properties of Baltimore biopark developer for $1.5 bil..
2016 VENTAS : to acquire South Street Landing investor Wexford for $1.5 billion
2016 VENTAS : to Acquire Life Science and Medical Real Estate Assets of Wexford for $..
2016 VENTAS : to Acquire High-Quality Life Science and Medical Real Estate Leased By ..
2016 BRIEF : Ventas to acquire Wexford's real estate
2016 VENTAS : Announces Pricing of Common Stock Offering
2016DJVentas Signs $1.5 Billion Life Sciences-Focused Deal
2016 VENTAS : Announces Public Offering of 9,000,000 Shares of Common Stock
2016 VENTAS : to Acquire High-Quality Life Science and Medical Real Estate Leased By ..
2016DJVENTAS : Signs $1.5 Billion Life Sciences-Focused Deal
2016 VENTAS INC : Change in Directors or Principal Officers, Financial Statements and..
2016 VENTAS : Elects Walter C. Rakowich and Roxanne M. Martino to Board of Directors
2016 VENTAS : to Participate in NAREIT REITWeek 2016 Conference
2016 VENTAS INC : Other Events, Financial Statements and Exhibits (form 8-K)
2016 VENTAS : Announces Results of Tender Offer for 1.55% Senior Notes Due 2016
2016 VENTAS, INC. : ex-dividend day
1  2  3  4  5  6Next
Advertisement
Financials ($)
Sales 2017 3 542 M
EBIT 2017 858 M
Net income 2017 626 M
Debt 2017 10 985 M
Yield 2017 4,98%
P/E ratio 2017 28,38
P/E ratio 2018 32,75
EV / Sales 2017 9,38x
EV / Sales 2018 9,19x
Capitalization 22 242 M
More Financials
Chart VENTAS, INC.
Duration : Period :
Ventas, Inc. Technical Analysis Chart | VTR | US92276F1003 | 4-Traders
Full-screen chart
Technical analysis trends VENTAS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 63,1 $
Spread / Average Target 0,57%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Debra A. Cafaro Chairman & Chief Executive Officer
Robert F. Probst Chief Financial Officer & Executive Vice President
John K. Hart Chief Information Officer & Senior Vice President
Jay M. Gellert Independent Director
James D. Shelton Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VENTAS, INC.0.45%22 242
WELLTOWER INC0.01%24 543
HCP, INC.5.65%14 813
OMEGA HEALTHCARE INVES..2.18%6 256
HEALTHCARE TRUST OF AM..7.49%4 454
MEDICAL PROPERTIES TRU..8.46%4 198
More Results